Skip to Main Content

Author Details

Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
1993
348
56
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36597483Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI.Heliyon2023
37967532Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer.Immunity2023
37965314Cytotoxic CD4<sup>+</sup> T cells in chronic viral infections and cancer.Front Immunol2023
37520539Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.Front Immunol2023
37517633Janus kinase-inhibition modulates hepatitis E virus infection.Antiviral Res2023
37515072Influence of the Single Nucleotide Polymorphisms rs12252 and rs34481144 in <i>IFITM3</i> on the Antibody Response after Vaccination against COVID-19.Vaccines (Basel)2023
37883584Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles.PLoS Pathog2023
37874130Targeted mutations in IFNα2 improve its antiviral activity against various viruses.mBio2023
38094304Fatty acids are crucial to fuel NK cells upon acute retrovirus infection.Front Immunol2023
35779233Impact of low eGFR on the immune response against COVID-19.J Nephrol2023
37414153SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection.Virol Sin2023
37380654Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019.Sci Rep2023
37208323Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients.Nat Commun2023
37112757Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients.Vaccines (Basel)2023
37006290Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study.Front Immunol2023
37006279COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study.Front Immunol2023
37199727HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance.Clin Cancer Res2023
37427590Regulatory T cells suppress the motility of cytotoxic T cells in Friend retrovirus-infected mice.JCI Insight2023
37092613Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Response.Acta Biomed2023
36851312Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State.Vaccines (Basel)2023
36786264Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population.Acta Biomed2023
36916726A systematic comparison reveals dynamic differences in early adaptive immune responses of acute-resolving versus chronic HBV replication.J Med Virol2023
35084382Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice.AIDS2022
35536867Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies.PLoS Negl Trop Dis2022
35368148HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.Hepatol Commun2022
35812411Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections.Front Immunol2022
36447206Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro.BMC Biol2022
36615083Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients.J Clin Med2022
36458014SRSF1 acts as an IFN-I-regulated cellular dependency factor decisively affecting HIV-1 post-integration steps.Front Immunol2022
35911692Distinct Type I Interferon Subtypes Differentially Stimulate T Cell Responses in HIV-1-Infected Individuals.Front Immunol2022
36073812CCL2: a Chemokine Potentially Promoting Early Seeding of the Latent HIV Reservoir.mBio2022
36311794IFNα subtype-specific susceptibility of HBV in the course of chronic infection.Front Immunol2022
36105097<i>GNB3</i> c.825c&gt;T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine.Front Genet2022
36091146COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion rates.Front Oncol2022
36016235Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients.Vaccines (Basel)2022
35943879Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy.Hum Gene Ther2022
35131898Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.Proc Natl Acad Sci U S A2022
35126368Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection.Front Immunol2022
35214785Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis.Vaccines (Basel)2022
35214596The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts.Vaccines (Basel)2022
35145522Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination.Front Immunol2022
34905514Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C.JCI Insight2022
35174107HBeAg Is Indispensable for Inducing Liver Sinusoidal Endothelial Cell Activation by Hepatitis B Virus.Front Cell Infect Microbiol2022
32333814Functional Comparison of Interferon-α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon-α and Interferon-γ Signaling.Hepatology2021
33794040The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection.Liver Int2021
33572306Seasonality of Non-SARS, Non-MERS Coronaviruses and the Impact of Meteorological Factors.Pathogens2021
33906918Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.mBio2021
33737955Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection.Ther Adv Neurol Disord2021
33711707The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.Cytokine2021
33540061Delivery of toll-like receptor 3 ligand poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model.Acta Biomater2021
  • 1 - 50 of 348

Recommended Authors

University of Alabama at Birmingham
Career Start Year 2014
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2011
Number of shared co-authors 1
University of Wisconsin
Career Start Year 2010
Number of shared co-authors 0
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 1
Texas Biomedical Research Institute
Career Start Year 2004
Number of shared co-authors 0
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 0
University of Virginia
Career Start Year 2003
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 10
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 2
George Washington University
Career Start Year 2000
Number of shared co-authors 3
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 4
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 10
Yale University
Career Start Year 1990
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 9
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 1
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 5
Wistar Institute
Career Start Year 1986
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 3
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 3
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 2
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 10
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 5
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 11
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 2
University of Texas San Antonio
Career Start Year 1971
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 1
Wistar Institute
Career Start Year 1958
Number of shared co-authors 2

Collaborators

National Institute of Allergy and Infectious Diseases
Co-authored papers 46
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 17
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Co-authored papers 14
Co-authored papers 11
Co-authored papers 9
Co-authored papers 8
Co-authored papers 7
Co-authored papers 4
University of California berkeley
Co-authored papers 3
National Institute of Allergy and Infectious Diseases
Co-authored papers 2
Co-authored papers 2
Erasmus Medical Center
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Institute for Artificial Intelligence, University of Duisburg-Essen
Co-authored papers 2
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Center for Computational Biology, University of California berkeley
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Zhongnan Hospital of Wuhan University
Co-authored papers 1
University of California, USA Gladstone Institutes san francisco
Co-authored papers 1
Co-authored papers 1
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
Co-authored papers 1
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
Co-authored papers 1
University of Tennessee Health Science Center
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1